Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Palantir Stock Is Beloved by Some Investors

By Chris Lau, InvestorPlace Contributor

The long-term outlook of PLTR stock is upbeat because of the company's growing customer base and strengthening products.

7 Crypto-Related Stocks to Consider for a Bitcoin-Style Surge

By Chris Lau, InvestorPlace Contributor

These hot crypto stocks are a buy for investors looking to jump into the market without purchasing cryptocurrency.

Sell RIDE Stock After Ugly Earnings Mix and Soaring Costs

By Chris Lau, InvestorPlace Contributor

Lordstown has limited upside appeal as mounting costs outweigh the long-term revenue potential from an increasingly crowded EV market.

Sell QuantumScape Stock at Any Opportunity

By Chris Lau, InvestorPlace Contributor

QuantumScape's spending is rising and on an unsustainable path. Investors should sell QS stock as soon as it starts to rally.

Why Sundial Stock Has Many Positive Upside Catalysts Ahead

By Chris Lau, InvestorPlace Contributor

Sundial is a favorite trade among cannabis investors but the eventually sustaining profits in the long-term will lift its prospects.

Load More